Early coronavirus drug trials tested vaccines mostly on White people; next phase aims for diversity

The first large-scale efficacy trials of potential Covid-19 vaccines in the U.S. began Monday. A key priority is recruiting participants of diverse backgrounds. It may be a challenge.